<h4>Objectives</h4>Bioinformatics analysis suggests that the A-Raf proto-oncogene serine/threonine kinase (ARAF) is closely associated with bladder cancer and the mitogen-activated protein kinase (MAPK) pathway. Here, MARK2 is linked to urinary bladder carcinoma.